Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States

Michele Wilson, Yoav Golan, Dianne Nguyen, Morteza Yazdani, Alpesh N. Amin

Open source

DOI
10.1007/s40121-025-01169-4
Published
2025-07-09
Container
Infectious Diseases and Therapy
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40121-025-01169-4,
  title = {Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States},
  author = {Michele Wilson and Yoav Golan and Dianne Nguyen and Morteza Yazdani and Alpesh N. Amin},
  year = {2025},
  journal = {Infectious Diseases and Therapy},
  doi = {10.1007/s40121-025-01169-4},
  url = {https://doi.org/10.1007/s40121-025-01169-4}
}

RIS

TY  - JOUR
TI  - Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States
AU  - Michele Wilson
AU  - Yoav Golan
AU  - Dianne Nguyen
AU  - Morteza Yazdani
AU  - Alpesh N. Amin
PY  - 2025
JO  - Infectious Diseases and Therapy
DO  - 10.1007/s40121-025-01169-4
UR  - https://doi.org/10.1007/s40121-025-01169-4
ER  - 

APA

Wilson, M., Golan, Y., Nguyen, D., Yazdani, M., & Amin, A. N. (2025). Budget Impact Analysis of Fecal Microbiota Spores, Live-brpk (Formerly SER-109) for Recurrent Clostridioides difficile Infection in the United States. Infectious Diseases and Therapy. https://doi.org/10.1007/s40121-025-01169-4

Source records